Results 151 to 160 of about 18,807 (198)

Predictive factors for poor outcome in pediatric C3 glomerulonephritis. [PDF]

Fukushima J Med Sci, 2018
Hosoya M, Kawasaki Y, Maeda R, Sato M, Suyama K, Hashimoto K, Hosoya M.   +6 more
europepmc   +1 more source

C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report. [PDF]

BMC Nephrol, 2018
Alonso-Titos J, Perea-Ortega L, Sola E, Torres-Rueda A, León M, Toledo R, Duarte AD, Vazquez T, Martinez-Esteban MD, Bailen A, Ruiz-Esteban P, Hernandez D.   +11 more
europepmc   +1 more source

Significance of serum C3 in glomerulonephritis.

The Indian journal of medical research, 1978
V, Khanijo, C, Prabha, K, Saha, S N, Rizvi, P D, Gulati   +4 more
openaire   +1 more source

Poststreptococcal acute glomerulonephritis superimposed on chronic kidney disease due to dysplastic kidney in an 11-year-old boy. [PDF]

CEN Case Rep
Okada S, Kamei K, Nishi K, Kitakado H, Ogura M, Yoshioka T, Ogata K, Oda T.   +7 more
europepmc   +1 more source

Case Report: Successful treatment of <i>Bartonella henselae</i>-associated crescentic glomerulonephritis in renal transplant recipient. [PDF]

Front Med (Lausanne)
Pierson S, Chabannes M, Lang S, Colladant M, Seibel J, Bamoulid J, Ducloux D, Courivaud C, Felix S, Crepin T.   +9 more
europepmc   +1 more source

When Atypical Becomes Typical: A Fulminant Seronegative Anti-GBM Disease. [PDF]

Kidney Med
Andrawes-Barbara FY, Jiries G, Vdovitch O, Ben-Izhak O, Kruzel-Davila E.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Membranoproliferative Glomerulonephritis und C3‑Glomerulopathie

Der Internist, 2019
Based on an increasingly better pathophysiological understanding over the last 10 years, in 2010 a new classification of glomerulonephritis with dominant or codominant C3 deposits was introduced and the predominant subgoup was termed C3 glomerulopathy (C3G). In the current classification, immune complex mediated membranoproliferative glomerulonephritis
B, Hohenstein, K, Amann, J, Menne
openaire   +2 more sources

Eculizumab in post-transplant C3 glomerulonephritis caused by a C3 mutation

Clinical Nephrology, 2020
C3 glomerulonephritis (C3GN) is a disorder of excess alternative complement activation leading to glomerular injury. Following kidney transplantation, C3GN has a high recurrence rate, and the overall prognosis is poor without treatment. However, treatment efficacy is highly variable.
Joon S, Kim, Kirk W, Foster, Scott G, Westphal   +2 more
openaire   +2 more sources

C3 glomerulonephritis with a severe crescentic phenotype

Pediatric Nephrology, 2017
C3 glomerulopathy (C3G) is rare type of glomerulonephritis resulting from the glomerular deposition of C3 due to dysregulation of the alternative pathway of complement. It is further subdivided into C3 glomerulonephritis (C3GN) and dense deposit disease (DDD), depending on the ultrastructural features. C3GN usually presents with a membranoproliferative
Aishwarya Ravindran, Fernando C. Fervenza, Richard J. H. Smith, Sanjeev Sethi   +3 more
openaire   +2 more sources